SIRT6 and breast cancer: The tumor suppressor FoxO3a increases its levels of acetylation in mouse embryonic fibroblasts depleted of SIRT6, whereas its induction by epirubicin is attenuated in breast cancer cells overexpressing SIRT6 [65].